Frederick M. Hudson Supernus Pharmaceuticals, Inc. (SUPN) insider trading activity

Frederick M. Hudson is Director of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 48,395 shares of SUPN, which is worth approximately $1.86 Million. The most recent transaction as insider was on Jan 22, 2025, when has been sold 20,000 shares (Common Stock) at a price of $9.13 per share, resulting in proceeds of $182,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.4K

70.43% 3M change

45.63% 12M change

Total Value Held $1.86 Million

Frederick M. Hudson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 22 2025	BUY Exercise of conversion of derivative security	$182,600 $9.13 p/Share	20,000 Added 29.24%	48,395 Common Stock
Nov 08 2024	SELL Open market or private sale	$316,434 $36.28 p/Share	8,722 Reduced 23.5%	28,395 Common Stock
Feb 23 2024	BUY Grant, award, or other acquisition	-	3,886 Added 9.48%	37,117 Common Stock
Nov 15 2023	SELL Open market or private sale	$259,150 $28.5 p/Share	9,093 Reduced 21.48%	33,231 Common Stock
Nov 15 2023	BUY Exercise of conversion of derivative security	$68,902 $9.24 p/Share	7,457 Added 14.98%	42,324 Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	3,882 Added 10.02%	34,867 Common Stock
Jan 10 2023	BUY Exercise of conversion of derivative security	$68,903 $7.9 p/Share	8,722 Added 21.97%	30,985 Common Stock
Feb 19 2022	BUY Grant, award, or other acquisition	-	4,222 Added 15.94%	22,263 Common Stock

Also insider at

SCPH

scPharmaceuticals Inc. Healthcare

FMH